Abstract
The feasibility of targeted screening for cutaneous malignant melanoma in the UK using a postal questionnaire and invitation to screening by a consultant dermatologist was investigated in a population based cross-sectional survey. A total of 1600 people aged 25–69 years, stratified by the social deprivation score of wards within one general practice, were randomly selected from a population of 8000.1227 (77%) returned the questionnaire and 896 (56%) attended the screening clinic. Uptake was lower for men (P< 0.001), those aged under 50 (P< 0.001), people from deprived areas (P< 0.001) and skin types III and IV (men only, P< 0.001). Twenty per cent of women and 10% of men felt nervous about attending the clinic, but only 4% were worried by the questionnaire. The level of agreement between the self- and dermatologist's assessments of risk factors was best for hair colour (Kappa = 0.67, sensitivity 73% and specificity 98%). People tended to under-report their level of risk. Over 95% knew about at least one major sign, but 54% reported incorrect signs of melanoma. Targeted screening for melanoma in the UK will be hampered by difficulties in accurately identifying the target population. Strategies to improve skin self-awareness rather than screening should be developed and evaluated. © 2000 Cancer Research Campaign
Keywords: melanoma, screening, early detection
Full Text
The Full Text of this article is available as a PDF (75.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bataille V., Grulich A., Sasieni P., Swerdlow A., Newton Bishop J., McCarthy W., Hersey P., Cuzick J. The association between naevi and melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia. Br J Cancer. 1998;77(3):505–510. doi: 10.1038/bjc.1998.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Elwood J. M. Screening for melanoma and options for its evaluation [see comment]. J Med Screen. 1994 Jan;1(1):22–38. doi: 10.1177/096914139400100107. [DOI] [PubMed] [Google Scholar]
- Fariñas-Alvarez C., Ródenas J. M., Herranz M. T., Delgado-Rodríguez M. The naevus count on the arms as a predictor of the number of melanocytic naevi on the whole body. Br J Dermatol. 1999 Mar;140(3):457–462. doi: 10.1046/j.1365-2133.1999.02709.x. [DOI] [PubMed] [Google Scholar]
- Jackson A., Wilkinson C., Ranger M., Pill R., August P. Can primary prevention or selective screening for melanoma be more precisely targeted through general practice? A prospective study to validate a self administered risk score. BMJ. 1998 Jan 3;316(7124):34–39. doi: 10.1136/bmj.316.7124.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Keeley D. Screening for melanoma risk is misguided. BMJ. 1995 Apr 8;310(6984):916–916. doi: 10.1136/bmj.310.6984.916. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Landis J. R., Koch G. G. The measurement of observer agreement for categorical data. Biometrics. 1977 Mar;33(1):159–174. [PubMed] [Google Scholar]
- Little P., Keefe M., White J. Self screening for risk of melanoma: validity of self mole counting by patients in a single general practice. BMJ. 1995 Apr 8;310(6984):912–916. doi: 10.1136/bmj.310.6984.912. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MacKie R. M. Clinical recognition of early invasive malignant melanoma. BMJ. 1990 Nov 3;301(6759):1005–1006. doi: 10.1136/bmj.301.6759.1005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MacKie R. M., Freudenberger T., Aitchison T. C. Personal risk-factor chart for cutaneous melanoma. Lancet. 1989 Aug 26;2(8661):487–490. doi: 10.1016/s0140-6736(89)92097-7. [DOI] [PubMed] [Google Scholar]
- MacKie R. M., Hole D. Audit of public education campaign to encourage earlier detection of malignant melanoma. BMJ. 1992 Apr 18;304(6833):1012–1015. doi: 10.1136/bmj.304.6833.1012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Melia J. Early detection of cutaneous malignant melanoma in Britain. Int J Epidemiol. 1995;24 (Suppl 1):S39–S44. doi: 10.1093/ije/24.supplement_1.s39. [DOI] [PubMed] [Google Scholar]
- Ringborg U., Lagerlöf B., Broberg M., Månsson-Brahme E., Platz A., Thörn M. Early detection and prevention of cutaneous malignant melanoma: emphasis on Swedish activities. Med Oncol Tumor Pharmacother. 1991;8(3):183–187. doi: 10.1007/BF02987178. [DOI] [PubMed] [Google Scholar]
- Törnberg S., Månsson-Brahme E., Lindén D., Ringborg U., Krakau I., Kärnell R., Landegren J., Brandberg Y., Hakulinen T. Screening for cutaneous malignant melanoma: a feasibility study. J Med Screen. 1996;3(4):211–215. doi: 10.1177/096914139600300411. [DOI] [PubMed] [Google Scholar]